Correlation Between Delta 9 and Eagle Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Delta 9 and Eagle Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Delta 9 and Eagle Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Delta 9 Cannabis and Eagle Pharmaceuticals, you can compare the effects of market volatilities on Delta 9 and Eagle Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Delta 9 with a short position of Eagle Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Delta 9 and Eagle Pharmaceuticals.
Diversification Opportunities for Delta 9 and Eagle Pharmaceuticals
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Delta and Eagle is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Delta 9 Cannabis and Eagle Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eagle Pharmaceuticals and Delta 9 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Delta 9 Cannabis are associated (or correlated) with Eagle Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eagle Pharmaceuticals has no effect on the direction of Delta 9 i.e., Delta 9 and Eagle Pharmaceuticals go up and down completely randomly.
Pair Corralation between Delta 9 and Eagle Pharmaceuticals
Assuming the 90 days horizon Delta 9 Cannabis is expected to generate 2.15 times more return on investment than Eagle Pharmaceuticals. However, Delta 9 is 2.15 times more volatile than Eagle Pharmaceuticals. It trades about 0.01 of its potential returns per unit of risk. Eagle Pharmaceuticals is currently generating about -0.09 per unit of risk. If you would invest 6.40 in Delta 9 Cannabis on August 31, 2024 and sell it today you would lose (5.60) from holding Delta 9 Cannabis or give up 87.5% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 92.12% |
| Values | Daily Returns |
Delta 9 Cannabis vs. Eagle Pharmaceuticals
Performance |
| Timeline |
| Delta 9 Cannabis |
| Eagle Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Delta 9 and Eagle Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Delta 9 and Eagle Pharmaceuticals
The main advantage of trading using opposite Delta 9 and Eagle Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Delta 9 position performs unexpectedly, Eagle Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eagle Pharmaceuticals will offset losses from the drop in Eagle Pharmaceuticals' long position.The idea behind Delta 9 Cannabis and Eagle Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Eagle Pharmaceuticals vs. ANI Pharmaceuticals | Eagle Pharmaceuticals vs. Phibro Animal Health | Eagle Pharmaceuticals vs. Prestige Brand Holdings | Eagle Pharmaceuticals vs. Collegium Pharmaceutical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |